$480,876
|
To support research to inform the development of an IUD self-removal device.
|
2022 - 2023
|
LJAF
|
$181,083
|
To examine how prescription drugs can be developed by a nonprofit company.
|
2020 - 2022
|
LJAF
|
$220,000
|
To analyze the Georgia Medicaid program?s new payment models for contraceptive access
|
2020 - 2022
|
LJAF
|
$300,000
|
To examine key factors that impact the availability of long acting reversible contraceptive methods at Federally Qualified Health Centers and disseminating key findings.
|
2018 - 2019
|
LJAF
|